Agency News: Concentric Pharma Advertising, Intouch Solutions

Share this article:

Full-service agency Concentric Pharma Advertising has announced that business transfer organization MDC Partners has acquired a majority stake in the firm. This acquisition marks MDC Partners's first significant stake in healthcare marketing in the US, already having been established as a company with a valued network of shops in the consumer world, including innovative ad firm Crispin Porter + Bogusky. With offices in New York and London, Concentric's current roster of pharma clients includes Pfizer, Novartis, Amgen, Allergan and Genentech, in addition to being named as the AOR for the rheumatology indication of Enbrel, a product of Pfizer and Amgen. Financials for this transaction were undisclosed.

Kansas City-headquartered digital agency Intouch Solutions has brought its nationwide office count to three, after opening a third branch of the company today in Midtown Manhattan. The company opened up a second office, in Chicago, in 2008. Intouch has also announced its first hire at its New York City location: Jack Lipton, SVP, client services, who joined the agency this month after gaining extensive pharma marketing experience with agencies such as GQ and MRM, to name a few. At present, senior management from Intouch's Kansas head office will oversee the business's operations in New York.

Share this article:

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.